image 2 image 4
Skip Navigation Links
 Home 
 Congress Structure 
 Important Dates 
 Venue 
 Pre Registered 
 Hotel Info 
 Abstracts 
 Scientific Program 
 Social Program 
 Exhibition 
 Contact Us 
 Archive 
       XXIII Annual Congress of the Iranian Society of Ophthalmology        بـیــست و سومین کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران
مقاله Abstract


Title: The effect of intracameral injection of Bevacizumab on posterior capsular opacification after congenital cataract surgery
Author(s): Mohammadreza Talebnejad M.D, Gholamabbas Roustaei M.D, Mansour Rahimi M.D
Presentation Type: Poster
Subject: Cornea and Anterior Segment
Others:
Presenting Author:
Name: Mohammad reza Talebnejad
Affiliation :(optional) Poostchi Eye Research Center ,Shiraz University of Medical Sciences
E mail: talebnejadmr@yahoo.com
Phone: 07112302830
Mobile: 09171311993
Purpose:

Posterior capsular opacification (PCO) is the most common complication of cataract surgery especially in pediatric age group. Bevacizumab in addition to have antiangiogenesis effect has decreased the proliferation of the fibroblasts and epithelial cells and maybe intracameral injection of bevacizumab after cataract surgery can reduce or postpone the occurrence of PCO.

Methods:

Four patients were included in the study. Patients underwent phacoaspiration and intraocular lens implantation and one eye of each patient randomly assigned to either receiving intracameral bevacizumab (ICB) 1.25 mg/0.05 ml or BSS as control. Image processing and calculating PCO score were done using an Objective System Capsule Analysis (OSCA).

Results:

At 2 months, a mean OSCA PCO score of 0.4346 ± 0.2191 and 0.7709 ± 0.5275 were found for the ICB and control group respectively. The values were 0.8782 ± 0.2015 and 1.2291 ± 0.2820 for the ICB and control group respectively. There were no significant difference of the mean OSCA PCO score between the two groups at 2 month and 1 year postoperatively (p = 0.284 and p = 0.089, respectively).

Conclusion:

Although one year PCO score at the ICB group was less than that of the controls, the difference was not statistically significant.

Attachment: 444Dr Talebnejad.pptx





Skip Navigation Links
        صفحه اصلی
        ساختار کنگره
        تاریخ های مهم
        مکان برگزاری
        ثبت نام شدگان
        اطلاعات هتل - رزرو
        ارسال مقالات
        برنامه کنگره
        برنامه های جانبی
        نمایشگاه
        تماس با ما
        آرشیو کنگره سالهای گذشته
        جستجوی سخنران
 
Last News

  - بـیــست و سومین کنــگــره سـالیـانه انـجـمـن چـشـم پـزشـکی ایـــران